Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Phreesia Inc. (PHR:NYSE), powered by AI.
Phreesia Inc. is currently trading at $9.44. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Phreesia Inc. on Alpha Lenz.
Phreesia Inc.'s P/E ratio is 244.5.
“Phreesia Inc. trades at a P/E of 244.5 (premium valuation) with modest ROE of 0.8%. 3Y revenue CAGR of 19.6% highlights clear growth momentum.”
Ask for details →Phreesia Inc. is a healthcare technology company that provides patient intake and engagement solutions for medical practices. Its primary function is to streamline the patient registration and intake process through digital tools, enhancing both operational efficiency and patient experience. Phreesia's platform offers a range of services, including appointment scheduling, insurance verification, and payment processing, helping healthcare providers optimize administrative workflows and focus more on patient care. By integrating with other health IT systems, Phreesia influences sectors such as outpatient clinics, specialty practices, and hospitals, ensuring seamless data capture and communication across healthcare teams. In the broader financial market, Phreesia Inc. plays a significant role by addressing the growing demand for digital transformation in the healthcare sector, which is driven by the need for efficiency and improved patient satisfaction. Established in 2005, Phreesia continues to innovate with solutions that cater to the evolving needs of healthcare providers in managing patient interactions and delivering quality care.
“Phreesia Inc. trades at a P/E of 244.5 (premium valuation) with modest ROE of 0.8%. 3Y revenue CAGR of 19.6% highlights clear growth momentum.”
Ask for details →Phreesia Inc. (ticker: PHR) is a company listed on NYSE in the Healthcare sector (Health Information Services). It has approximately 2,082 employees. Market cap is $564M.
The current price is $9.44 with a P/E ratio of 244.55x and P/B of 1.67x.
ROE is 0.77% and operating margin is -1.38%. Annual revenue is $481M.